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Conclusions
This study showed that successful cather ablation can improve LA function of patients
with drug-refractory PAF.
1038-154 Pharmacologic and Carbon Dioxide Reactivity of 
Coronary Circulation as Determined by Computed 
Tomography Perfusion
Aaron So, Ting-Yim Lee, Robarts Research Institute, London, ON, Canada, Lawson 
Health Research Institute, London, ON, Canada
Background
Dobutamine and dipyridamole are routinely used to activate coronary perfusion reserve
to detect ischemia. This study investigates the different effects of these two drugs on cor-
onary circulation and compare them to arterial carbon dioxide tension (PaCO2).
Methods
8 dogs were used to study coronary perfusion reactivity to arterial PaCO2 (n = 3), dob-
utamine (DOB, n = 4) and dipyridamole (DIP, n = 1). Myocardial perfusion (MBF), blood
volume (MBV) and mean transit time (MTT) were measured in each study by injecting a
bolus of contrast followed by cine CT scanning for 30 s using a General Electric Medical
Systems (GEMS) LightSpeed Plus multi-slice CT scanner. Reconstructed images at end-
diastole were selected to generate functional maps using CT Perfusion (GEMS). For
PaCO2 studies, measurements on each dog were taken twice at hypo- (24 ± 4 mmHg),
normo- (33 ± 5 mmHg) and hyper-capnia (50 ± 5 mmHg). For DOB studies, measure-
ments on each dog were repeated once both before and after constant infusion of DOB
for 7 minutes (0.25 mg/kg). For DIP studies, repeat measurements were also obtained
before and after DIP infusion for 4 minutes (0.56 mg/kg).
Results
DIP, DOB and hypercapnia increased MBF by 3.2, 3.3 and 2.0 times relative to baseline
respectively (p < 0.05). Both drug-induced increases in MBF were different from that at
hypercapnia (p < 0.01). MBV increased by 1.5 times at hypercapnia (p < 0.05) and with
DIP stress (p > 0.05) relative to baseline, while with DOB the increase was 3.1 times (p <
0.01) and was different from the increase at hypercapnia (p < 0.01) and with DIP stress
(p < 0.05). Significant reduction in MTT was seen at hypercapnia (0.7 times, p < 0.01)
and with DIP stress (0.5 times, p < 0.05) relative to baseline, but not with DOB (1.0 times,
p > 0.1). All functional parameters were not different between hypo- and normo-capnia (p
> 0.05).
Conclusion
These preliminary findings suggested that DIP increases MBF by coronary vasodilation
since there is a moderate increase in MBV and a large decrease in MTT. In contrast,
DOB increases MBF via coronary recruitment since there is a large increase in MBV and
essentially no change in MTT. Furthermore, coronary circulation is more responsive to
hypercapnia than hypocapnia. 
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1054-145 Murine Cardiac Failure Model Produced by High-
Intensity Focused Ultrasound
Ryo Otsuka, Kana Fujikura, Kumiko Hirata, Todd Pulerwitz, Robert Muratore, David 
Engel, Daniel Burkhoff, Jie Wang, Fred Lizzi, Shunichi Homma, Columbia University, 
New York, NY, River Side Institute, New York, NY
Background: High intensity focused ultrasound (HIFU) produces immediate focal lesions
with intense focused ultrasound exposures within short periods. Previously we reported
on the feasibility of creating thermal lesions using HIFU in in-vitro cardiac tissues. Cur-
rently, heart failure models are created by ligation of LAD, a technique requiring signifi-
cant training. We hypothesized that murine myocardial failure models may be created
using HIFU which would be simpler to perform than coronary ligation. The purpose of this
study was to assess the feasibility of cardiac failure model creation using HIFU in mice.
Methods: We studied 20 wild type mice (HIFU group). They were anesthetized and
underwent a left sided thoracotomy. The frequency of the transducer was 4.67 MHz, and
the focal zone was 10mm depth × 1.1 mm wide which was 25 mm from the transducer.
HIFU transducer surface was coupled with the left ventricular (LV) anterior wall using gel
and water bath. The focal point was set at the middle of LV wall. We used one second
duration of HIFU energy discharge (19.7kW/cm2) three times for each mouse. As a con-
trol group, 10 mice underwent identical procedure without HIFU discharge (Control).
Before and at 4 weeks from procedure, we assessed the LV diameter at end-systole (Ds)
and end-diastole (Dd) and ejection fraction (EF) using a high frequency ultrasound sys-
tem in both groups.
Results: The mortality of HIFU group was 25%. There was no significant difference of LV
Dd/Ds between the two groups before ablation (HIFU group vs. Control; 2.67±0.2/
1.35±0.17 vs. 2.59±0.24/1.34±0.15 mm, respectively). At 4 weeks, LV diameter in HIFU
group was significantly increased (3.54±0.54 vs. 2.67±0.2 mm, p<0.01). Before HIFU
ablation, there was no significant difference of LVEF between the two groups. LVEF in
control group did not changed significantly. However, LVEF in HIFU group was signifi-
cantly reduced after HIFU ablation (69.7±5.3% vs 48.4±13.7%, respectively; p<0.01).
Histopathological study showed a necrotic area around the ablation site and LV remodel-
ing.
Conclusion: HIFU can produce LV dilatation and systolic dysfunction in mice. HIFU may
be used to create a murine myocardial failure model.
1054-146 Feasibility of Focal Septal Myocardial Ablation Through 
the Right Ventricle Using High-Intensity Focused 
Ultrasound
Kana Fujikura, Ryo Otsuka, Todd Pulerwitz, Takeki Suzuki, Robert Muratore, Frederic L. 
Lizzi Eng, Shunichi Homma, Columbia Presbyterian Medical Center, New York, NY
Background: High intensity focused ultrasound (HIFU) is used clinically for ablating solid
tumors and for creating intra-ophthalmic lesions. However potential cardiac applications
have been limited. We have previously demonstrated the ability of HIFU to create focal
lesions in the myocardium. An important, potential use of HIFU is ablation of left ventricu-
lar (LV) septal tissue in patients with hypertrophic cardiomyopathy. In this case, it is nec-
essary to focus the beam through the right ventricular (RV) free wall at the septum
without damaging intervening tissue. The purpose of this study was to create a precise,
focal lesion in the LV septum without affecting the RV free wall.
Method: The LV septum with overlying RV free wall of a calf heart was placed in
degassed saline bath at 37ºC. The operating frequency of the transducer was 4.67MHz
with an acoustic power of 26.9kW/cm2. Our HIFU machine is designed to create a focal
zone 10.0-mm×1.0-mm, at a depth of 25-mm from the transducer. The transducer was
coupled to the surface of the RV free wall using ultrasound gel and focused on the ven-
tricular septum. In order to simulate ablation during cardiac contractions, the HIFU trans-
ducer was set to deliver ten 0.4 second duration pulses over a 10 second period. Four
lesions were created in different septal areas by moving the transducer. All specimens
were cut and histopathological sections prepared in order to determine lesion size.
Result: All lesions were visibly detected. The mean lesion size in the septum was 3.5±0.7
mm2. No visible or histological damage of the RV free wall was detected in the path of the
HIFU beam.
Conclusion: HIFU creates well demarcated lesions in the LV septum without damaging
intervening tissue. With further development, this device may prove useful for LV septal
ablation in patients with hypertrophic cardiomyopathy.
1054-147 Use of Color M-Mode Tissue Doppler Imaging to 
Calculate Dynamic Compliance of the Pulmonary 
Arteries in Pulmonary Hypertension: Validation in an 
Animal Model
Bibhuti B. Das, Janice M. Bright, June A. Boon, Hsiu-Mei Yao, Craig J. Lanning, Lilliam M. 
Valdes-Cruz, Robin Shandas, University of Colorado Health Sciences Center/The 
Children's Hospital, Denver, CO, Colorado State University / College of Veterinary 
Medicine and Biomedical Sciences, Fort Collins, CO
Background: We have previously shown that dynamic compliance (Cdyn) of the pulmo-
nary artery (PA) provides important information on reactivity in patients with pulmonary
hypertension (PHT). However Cdyn requires invasive measurements. We have recently
developed a non-invasive method to assess Cdyn using color M-mode tissue Doppler
imaging (CMM-TDI). Here we validate this method in an animal model of PHT. Methods:
This study was performed in 7 anaesthetized dogs with no underlying PHT at baseline
and after infusion of 3 doses of a vasoconstrictor (thromboxane mimetic U46619). CMM-
TDI velocities from right PA walls were integrated using a custom algorithm to produce
instantaneous diameter. Compliance was calculated as: Cdyn (% diameter change / 100
mm Hg) = [((Ds – Dd)/(Ps x Dd) x 104); Ds, Dd = systolic, diastolic diameter; Ps = Peak
PA pressure] for all conditions (N = 30). Results: CMM-TDI provided consistently supe-
rior diameter measurements when compared to M-mode. A non-linear relationship
between Cdyn and mean PA pressure was found (Figure), showing decreased compli-
ance with increasing PA pressure, indicative of strain-stiffening behavior expected from
the non-linear mechanics of these arteries. Conclusion: CMM-TDI allows compliance of
the pulmonary vasculature to be obtained non-invasively. This method adds an important
tool to pulmonary reactivity evaluation. 
